New Research Explores Immuno-oncology Effectiveness for Lung Cancer in Medicare Population 

JAMA Network

05.21.21 Findings from HDAI and Dana-Farber Cancer Institute Real-world Evidence Study of 20,000 Medicare Patients Shows Shorter Survival Times than Observed in Clinical Trials   BOSTON, May 21, 2021 /PRNewswire/ — Health Data Analytics Institute (HDAI) – an innovator in healthcare AI solutions – and researchers at Dana-Farber Cancer Institute today announced publication of  findings exploring the effectiveness of immune checkpoint inhibition for […]